Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective
Massimo Dominici(University of Modena and Reggio Emilia), Kurt C. Gunter(Medica (United States)), Lynn O’Donnell(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Aaron Levine(Georgia Institute of Technology), John E.J. Rasko(Macau University of Science and Technology), Natividad Cuende(Junta de Andalucía), Leigh Turner(University of California, Irvine), William E. Janssen(St. Jude Children's Research Hospital), Edwin M. Horwitz(St. Jude Children's Research Hospital), Hong‐Nerng Ho(National Taiwan University), Robert Nordon(UNSW Sydney), Paul W. Eldridge(University of North Carolina at Chapel Hill), Miguel Forte(Txcell (France)), Dominic Wall(The University of Melbourne), Milton Artur Ruiz(Beneficência Portuguesa de São Paulo), Edwin Wagena, Karen Nichols(ImmunityBio (United States)), Robert Deans(Rubius Therapeutics (United States)), Chris Mason(Oak Ridge National Laboratory), Deborah Griffin(Moffitt Cancer Center), Steve D. Wilton(Murdoch University), Daniel J. Weiss(University of Vermont), Alok Srivastava(M.J.P. Rohilkhand University)
Cited by 55
Related Papers
A Brief Definition of Regenerative Medicine
|Regenerative Medicine|2007|795
BTRFS
|ACM Transactions on Storage|2013|381
Lancet Commission: Stem cells and regenerative medicine
|The Lancet|2017|276
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
|Haematologica|2021|236
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology
|Scientific Reports|2019|189